How Companies are Using Microbiome-Based Therapies to Improve Patient Outcomes

On Wednesday morning at the BIO Investor Forum, leaders from six companies at the forefront of microbiome innovation assembled to discuss the latest developments in microbiome-based approaches to improve patient outcomes, including microbiome transplants, bioengineered probiotics, next-generation antibiotics, and microbiome-based drug discovery platforms. Investments in microbiome-related companies have accelerated across the past three years, demonstrating high investor expectations for results